SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

被引：427
|
作者：
Poland, Gregory A. [1 ,2 ]
Ovsyannikova, Inna G. [1 ,2 ]
Kennedy, Richard B. [1 ,2 ]
机构：
[1] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN USA
来源：
LANCET | 2020年 / 396卷 / 10262期
关键词：
ANTIBODY-DEPENDENT ENHANCEMENT; COVID-19; INFECTION; DISEASE; CELLS;
D O I：
10.1016/S0140-6736(20)32137-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing vaccines, antivirals, and monoclonal antibodies. A mere 11 months ago, the canvas we call COVID-19 was blank. Scientists around the world have worked collaboratively to fill in this blank canvas. In this Review, we discuss what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials.
引用
收藏
页码：1595 / 1606
页数：12
相关论文
共 50 条
  • [1] A systematic review of SARS-CoV-2 vaccine candidates
    Dong, Yetian
    Dai, Tong
    Wei, Yujun
    Zhang, Long
    Zheng, Min
    Zhou, Fangfang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [2] A systematic review of SARS-CoV-2 vaccine candidates
    Yetian Dong
    Tong Dai
    Yujun Wei
    Long Zhang
    Min Zheng
    Fangfang Zhou
    Signal Transduction and Targeted Therapy, 5
  • [3] SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
    Kyriakidis, Nikolaos C.
    Lopez-Cortes, Andres
    Vasconez Gonzalez, Eduardo
    Barreto Grimaldos, Alejandra
    Ortiz Prado, Esteban
    NPJ VACCINES, 2021, 6 (01)
  • [4] SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
    Nikolaos C. Kyriakidis
    Andrés López-Cortés
    Eduardo Vásconez González
    Alejandra Barreto Grimaldos
    Esteban Ortiz Prado
    npj Vaccines, 6
  • [5] SARS-CoV-2 vaccine candidates in rapid development
    Li, Lifeng
    Guo, Pengbo
    Zhang, Xiaoman
    Yu, Zhidan
    Zhang, Wancun
    Sun, Huiqing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 644 - 653
  • [6] Innate immunity to SARS-CoV-2 infection: a review
    Abrahao Silva, Marcos Jesse
    Rodrigues, Yan Correa
    Batista Lima, Karla Valeria
    Gondim Costa Lima, Luana Nepomuceno
    EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [7] SARS-CoV-2 immunity
    Antonio Bertoletti
    Cellular & Molecular Immunology, 2024, 21 : 101 - 102
  • [8] SARS-CoV-2 immunity
    Bertoletti, Antonio
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (02) : 101 - 102
  • [9] New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
    Ura, Takehiro
    Yamashita, Akio
    Mizuki, Nobuhisa
    Okuda, Kenji
    Shimada, Masaru
    VACCINE, 2021, 39 (02) : 197 - 201
  • [10] Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
    Elder, Elizabeth
    Revanna, Chandrashekar Bangalore
    Johansson, Catharina
    Wallin, Robert P. A.
    Sjoedahl, Johan
    Winqvist, Ola
    Mirazimi, Ali
    VACCINE, 2023, 41 (32) : 4743 - 4751
12345